• Asian-Australasian Journal of Animal Sciences
• /
• 제29권12호
• /
• pp.1725-1733
• /
• 2016

Recent findings have shown that microbial nitrogen flow and digestible energy of diets are increased when urea is combined with a slow-release urea (SRU) in diets with a starch to acid detergent fibre ratio (S:F) 4:1. This affect is attributable to enhanced synchrony between ruminal N availability for microbial growth and carbohydrate degradation. To verify the magnitude of this effects on lamb performance, an experiment was conducted to evaluate the effects of combining urea and a SRU in diets containing S:F ratios of 3:1, 4:1, or 5:1 on performance, dietary energetics and carcass characteristics of finishing lambs. For that, 40 Pelibuey${\times}$Katahdin lambs ($36.65{\pm}3kg$) were assigned to one of five weight groupings in 20 pens (5 repetition/treatments). The S:F ratio in the diet was manipulated by partially replacing the corn grain and dried distiller's grain with solubles by forage (wheat straw) and soybean meal to reach S:F ratios of 3:1, 4:1 or 5:1. An additional treatment of 4:1 S:F ratio with 0.8% urea as the sole source of non-protein nitrogen was used as a reference for comparing the effect of urea combination vs. conventional urea at the same S:F ratio. There were no treatment effects on dry matter intake (DMI). Compared the urea combination vs urea at the same S:F ratio, urea combination increased (p<0.01) average daily gain (ADG, 18.3%), gain for feed (G:F, 9.5%), and apparent energy retention per unit DMI (8.2%). Irrespective of the S:F ratio, the urea combination improved the observed-to-expected dietary ratio and apparent retention per unit DMI was maximal (quadratic effect, $p{\leq}0.03$) at an S:F ratio of 4:1, while the conventional urea treatment did not modify the observed-to-expected net energy ratio nor the apparent retention per unit DMI at 4:1 S:F ratio. Urea combination group tended (3.8%, p = 0.08) to have heavier carcasses with no effects on the rest of carcass characteristics. As S:F ratio increased, ADG, G:F, dietary net energy, carcass weight, dressing percentage and longissimus thoracis (LM) area increased linearly ($p{\leq}0.02$). Combining urea and a slow-release urea product results in positive effects on growth performance and dietary energetics, but the best responses are apparently observed when there is a certain proportion (S:F ratio = 4:1) of starch to acid detergent fibre in the diet.

• 생태와환경
• /
• 제52권1호
• /
• pp.21-27
• /
• 2019

본 연구에서는 영농기간 동안 비강우시에 영농형태에 따른 논에서 유출되는 T-N, T-P, COD, SS의 적정 확률분포를 분석하기 위해 2016년 전라북도 부안군 논 유역에서 모니터링을 수행하였다. 확률분포모형 선정을 위해 Kolmogorov-Smirnov 검정방법을 적용한 결과 Weibull 분포모형에서 대조구, 완효성비료처리구, 물꼬관리처리구의 모든 수질 항목에서(T-N, T-P, COD, SS) 적합성이 있는 것으로 나타났다. 이는 강우시에 모든 수질 항목에서 Log-Normal 분포모형과 Gamma 분포모형에서 적합성이 있는 것으로 보고한 선행연구 결과와는 다른 특성을 보였다. 따라서, 하천의 수질관리를 위해서는 시기별 적합한 확률분포모형을 적용해야 한다. 본 연구 결과에서 분석된 비강우시 영농형태별 (대조구, 완효성비료처리구, 물꼬관리처리구) 확률분포모형에 의해 선정된 수질 항목별 중앙값과 하천의 수질을 연계 분석한다면 논에서 유출되는 수질이 하천에 미치는 영향을 분석할 수 있을 것으로 판단된다.

• Journal of Periodontal and Implant Science
• /
• 제27권4호
• /
• pp.751-765
• /
• 1997

치주질환은 세균에 의한 감염성 질환으로, 기계적 치태제거에 의한 치료의 한계를 극복하기 위하여 항세균 제재를 통한 화학적 치태 및 세균제거가 필요하게 되었다. 전신적으로 항생제를 투여할 경우 유효농도의 유지를 위해 많은 양의 약물이 투여되어야 하고, 여러가지 부작용의 위험이 있으므로, 이러한 단점을 극복하기 위한 국소 약물 송달체계가 필요하게 되었다. 본 실험의 목적은 치주질환 치료에 가장 많이 쓰이는 tetracycline을 calcium sulfate와 혼합하여, calcium sulfate의 서방형 국소 약물 송달효과에 대해 알아보고자 함이다. Modified calcium sulfate paste 와 10% tetracycline을 혼합한 것을 실험 1군으로, calcium sulfate와 10% tetracycline을 혼합하여 완전 경화 시킨 것을 실험 2군으로, calcium sulfate와 10% tetracycline을 혼합하여 경화되기 전에 사용한 것을 실험 3군으로, tetracycline-ethylene vinyl acetate fiber를 실험 4군으로 하여 시간별 tetracycline 방출농도, 유효농도 지속시간, calcium sulfate의 흡수기간 등을 관찰하여 다음과 같은 결론을 얻었다. 1. 실험 1군은 실험 5주까지 유효농도($4{\mu}g/ml$)이상의 농도를 유지하였고, 실험 2군은 실험 9일까지 유지하였으며, 실험 3군은 실험 7일까지 유효농도이상의 농도를 유지하였고, 실험 4군은 실험 15일까지 유지하였다. 2. 실험 2군은 평균 11.8일에 완전 용해 되었고, 실험 3군은 14.8일에 완전용해되었다. 3. 실험 2군과 3군은 실험 1주까지 방출된 tetracycline의 농도에 유의차를 보이지 않았다(p<0.05). 이상의 결과에서 볼 때, calcium sulfate는 tetracycline과 혼합하였을 때 일정 기간 동안 충분한 양의 tetracycline을 방출시키고, $11{\sim}14$일 정도 후에는 완전히 녹아 없어지므로, 서방형 국소 약물 송달 제재로서 가능성이 있으리라 생각된다.

• 약학회지
• /
• 제41권1호
• /
• pp.48-59
• /
• 1997

Sustained release matrix tablets, pellets, and coated pellets for the delivery of sulindac were prepared using cellulose derivatives at various ratios, and evaluated for the dis solution pattern. The release of sulindac, from matrix tablets prepared with low viscosity HPMC was relatively fast, and especially the tablets made of Metolose SM released all of sulindac within 1 hr. The release of drug from tablets made of other HPMC derivatives were retarded in the order of the following: Pharmacoat 645>Pharmacoat 606>Pharrnacoat 606+HPC-L>HPC-L. The most sustained release pattern was observed with the preparation of high viscous polymer. Metolose 90 SH. While release of sulindac, from matrix type pellet containing 10mg/cap of Metolose 90 SH or 60 SH was completed within 1 hr, a prolonged release formulation (30% in 1 hr) was obtained by the inclusion of EC. Pellets coated with HPMC showed a fast release pattern (${\geq}$ 80% within 2 hrs), whereas pellets coated with HPMC and EC (molar ratio 1 : 1) showed a sustained release pattern (${\geq}$ 80% in 12 hrs), vath the release from EC pellets being the most sustained. Fast (naked) and slow release pellets coated with EC, Metolose 60SH 50cps and propylene glycol. and enteric pellets coated with HPMCP 55 and Myvacet$^{\circledR}$ were prepared, and combined at various ratios for the assessment of dissolution pattern. The result indicates the possibility that the development of 24 hr sustained release delivery systems containing sulindac for oral administration could be achieved by means of combining sustained and fast release pellets at a proper portion.

• Archives of Pharmacal Research
• /
• 제15권2호
• /
• pp.162-168
• /
• 1992

Release characteristics of five different types of hydrophilic albumin microspheres (HAM) containing different ratios of methotrexate-albumin (MTX-HSA) conjugates to free MTX: 1 : 0 (HAMC), 3 :1 (HAMC 3F), 1 :1 (HAMCF), 1:3 (HAMCF3) and 0 : 1 (HAMF) were investigated in the absence or presence of protease using dissolution tester. In all the HAMs studied except HAMC, the MTX was released bi-exponentially in the absence of protease; an initial fast release period up to approximately 6h, and thereafter the release rate was very much slower. The fast release of MTX from the HAMs (such as HAMC3F, HAMCF, HAMCF3 and HAMF) at the initial phase in probably due to the release of "physically associated" MTX from the core of the HAMs. The initial rate constants were 7.2, 8.7, 8.5 and 5.9 times greater than the second rate constants for HAMF, HAMCF3, HAMCF and HAMC3F, respectively. MTX release from HAMC was very slow and mono-phasic. It was at most 2.2% of the total entrapped amount by 24 h. The protease accelerated the release of MTX from the HAMs. The percentages of MTX released from HAMs up to 24 h were 100, 89.0, 75.0, 66.0 and 61.0% for HAMF, HAMCF3, HAMCF, HAMC3F and HAMC, respectively in the presence of protease and the corresponding values in the absence of protease were 30.2 19.0, 10.0, 6.5 and 2.2%, respectively. In vitro release of MTX in the presence of protease varied according to the ratios of MTX-HSA conjugates to MTX; the data set from HAMF, HAMCF3 and HAMCF fits better to monophasic first-order profile more adequately than to zero-order profile, that of HAMC3 monophasic first-order, and that of HAMC to bi-phasic zero-order. Above results suggested that zero-order release rate can be achieved by adjusting the ratio of MTX-HSA conjugates to MTX in the preparation of HAMs such as HAMC3F.as HAMC3F.

• Journal of Pharmaceutical Investigation
• /
• 제35권6호
• /
• pp.453-460
• /
• 2005

4-Aminopyridine (AP) is a potassium channel blocker used in the treatment of neurological disorders such as multiple sclerosis and Alzheimer disease. AP‘s window of therapeutic effect appears to correlate with its plasma halflife (3.5 hours). It demonstrates pH-dependent solubility because of a weakly basic drug. In addition, the resulting release from conventional matrix tablets decreases with increasing pH-milieu of the gastrointestinal tract. The aim of this study is to design sustained release matrix tablet containing AP, overcoming this problem. $Eudragit^{\circledR}$ L 100 (EuL) and sodium alginate were used in an effort to achieve pH independent drug release. The effect of sodium alginate and EuL on drug release from matrix tablet was investigated. The drug release behavior from the different tablets was analyzed by $t_{20%},\;t_{40%},\;t_{60%}$, The exponential diffusion coefficient n, kinetic constant K were calculated according to the Korsmeyer-Peppas equation. The drug release from matrix tablets prepared with sodium alginate was decreased with increasing the content of sodium alginate in pH 7.4 while there is no significant difference in pH 1.2. The exponent n values were determined to be approximately 0.5 and 0.8 respectively, in both pH 1.2 and 7.4. These values indicate diffusion-based anomalous mechanism and erosion-based anomalous mechanism, respectively. The drug release from sodium alginate matrix tablets prepared with solid dispersion of EuL containing drug showed a slow drug release in an acidic medium and a more fast drug release in phosphate medium, compared with sodium alginate matrix tablets prepared with physical mixture. These results may be attributed to the gel forming ability of sodium alginate and pH dependent solubility of EuL. Therefore, sustained-release AP matrix tablets using sodium alginate and EuL were successfully prepared.

• 한국작물학회:학술대회논문집
• /
• 한국작물학회 2000년도 춘계 학술대회지
• /
• pp.148-149
• /
• 2000

• Journal of Periodontal and Implant Science
• /
• 제21권1호
• /
• pp.175.1-175.1
• /
• 1991

• 한국작물학회:학술대회논문집
• /
• 한국작물학회 1999년도 춘계 학술대회지
• /
• pp.73-74
• /
• 1999

• 한국잔디학회:학술대회논문집
• /
• 한국잔디학회 2005년도 학술대회지
• /
• pp.26-27
• /
• 2005